190 related articles for article (PubMed ID: 31247279)
1. Application of an adsorption isotherm to explain incomplete drug release from ordered mesoporous silica materials under supersaturating conditions.
Dening TJ; Zemlyanov D; Taylor LS
J Control Release; 2019 Aug; 307():186-199. PubMed ID: 31247279
[TBL] [Abstract][Full Text] [Related]
2. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
Dening TJ; Taylor LS
Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Drug Release and Adsorption under Supersaturating Conditions for Ordered Mesoporous Silica with Indomethacin or Indomethacin Methyl Ester.
McCarthy CA; Zemlyanov DY; Crean AM; Taylor LS
Mol Pharm; 2020 Aug; 17(8):3062-3074. PubMed ID: 32633973
[TBL] [Abstract][Full Text] [Related]
4. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations.
Hate SS; Reutzel-Edens SM; Taylor LS
Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797
[TBL] [Abstract][Full Text] [Related]
5. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems.
Hate SS; Reutzel-Edens SM; Taylor LS
Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416
[TBL] [Abstract][Full Text] [Related]
6. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
[TBL] [Abstract][Full Text] [Related]
7. Role of Drug Adsorption onto the Silica Surface in Drug Release from Mesoporous Silica Systems.
McCarthy CA; Ahern RJ; Devine KJ; Crean AM
Mol Pharm; 2018 Jan; 15(1):141-149. PubMed ID: 29219325
[TBL] [Abstract][Full Text] [Related]
8. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
Nairi V; Medda L; Monduzzi M; Salis A
J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
[TBL] [Abstract][Full Text] [Related]
9. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
[TBL] [Abstract][Full Text] [Related]
10. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
[TBL] [Abstract][Full Text] [Related]
12. Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.
Mellaerts R; Roeffaers MB; Houthoofd K; Van Speybroeck M; De Cremer G; Jammaer JA; Van den Mooter G; Augustijns P; Hofkens J; Martens JA
Phys Chem Chem Phys; 2011 Feb; 13(7):2706-13. PubMed ID: 21152589
[TBL] [Abstract][Full Text] [Related]
13. In situ FT-IR investigation of etravirine speciation in pores of SBA-15 ordered mesoporous silica material upon contact with water.
Mellaerts R; Fayad EJ; Van den Mooter G; Augustijns P; Rivallan M; Thibault-Starzyk F; Martens JA
Mol Pharm; 2013 Feb; 10(2):567-73. PubMed ID: 23252337
[TBL] [Abstract][Full Text] [Related]
14. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
[TBL] [Abstract][Full Text] [Related]
16. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica.
Van Speybroeck M; Mellaerts R; Mols R; Thi TD; Martens JA; Van Humbeeck J; Annaert P; Van den Mooter G; Augustijns P
Eur J Pharm Sci; 2010 Dec; 41(5):623-30. PubMed ID: 20850527
[TBL] [Abstract][Full Text] [Related]
17. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
[TBL] [Abstract][Full Text] [Related]
18. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
19. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.
Wang Z; Chen B; Quan G; Li F; Wu Q; Dian L; Dong Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():5807-18. PubMed ID: 23209366
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
